αvβ3 Integrin and Fibroblast growth factor receptor 1 (FGFR1): Prognostic factors in a phase I–II clinical trial associating continuous administration of Tipifarnib with radiotherapy for patients with newly diagnosed glioblastoma-Reference-Cited by-同舟云学术

αvβ3 Integrin and Fibroblast growth factor receptor 1 (FGFR1): Prognostic factors in a phase I–II clinical trial associating continuous administration of Tipifarnib with radiotherapy for patients with newly diagnosed glioblastoma

Published:2013-06 Issue:9 Volume:49 Page:2161-2169
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ducassou Anne,Uro-Coste Emmanuelle,Verrelle Pierre,Filleron Thomas,Benouaich-Amiel Alexandra,Lubrano Vincent,Sol Jean-Christophe,Delisle Marie-Bernadette,Favre Gilles,Ken Solea,Laprie Anne,De Porre Peter,Toulas Christine,Poublanc Muriel,Cohen-Jonathan Moyal Elizabeth

Funder

Janssen-Cilag

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

2. Inhibition of Rho pathways induces radiosensitization and oxygenation in human glioblastoma xenografts;Ader;Oncogene,2003

3. The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft;Delmas;Clin Cancer Res,2003

4. Farnesylated RhoB inhibits radiation-induced mitotic cell death and controls radiation-induced centrosome overduplication;Milia;Cell Death Differ,2005

5. RhoB controls the 24kDa FGF-2-induced radioresistance in HeLa cells by preventing post-mitotic cell death;Ader;Oncogene,2002

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased Cellular Uptake of ApoE3- or c(RGD)-Modified Liposomes for Glioblastoma Therapy Depending on the Target Cells;Pharmaceutics;2024-08-23

2. The molecular mechanisms of drug resistance of glioblastoma: differentiation and apoptosis;Russian Journal for Personalized Medicine;2024-01-16

3. Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance;Cancer Research Communications;2023-12-07

4. The molecular mechanisms of drug resistance of glioblastoma. Part 3. Differentiation and apoptosis of glioblastoma cells;Medical academic journal;2023-08-25

5. RhoB as a tumor suppressor: It’s all about localization;European Journal of Cell Biology;2023-06